EMA — authorised 6 January 2022
- Marketing authorisation holder: Amgen Europe BV
- Status: approved
🇪🇺 Lumakras in European Union
EMA authorised Lumakras on 6 January 2022
Marketing authorisation
Lumakras in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Lumakras approved in European Union?
Yes. EMA authorised it on 6 January 2022.
Who is the marketing authorisation holder for Lumakras in European Union?
Amgen Europe BV holds the EU marketing authorisation.